APA (7th ed.) Citation

Xiu, W., Guo, X., Yu, M., Li, Y., Xu, Y., Zhu, J., & Luo, J. (2022). Combination of Palliative Thoracic Radiotherapy With Bevacizumab for Stage IV Nonsquamous NSCLC: Is There Any Impact of Time Interval on Survival? Clinical Medicine Insights: Oncology, 1. https://doi.org/10.1177/11795549221106462

Chicago Style (17th ed.) Citation

Xiu, Weigang, Xiaotong Guo, Min Yu, Yanying Li, Yong Xu, Jiang Zhu, and Jingjing Luo. "Combination of Palliative Thoracic Radiotherapy With Bevacizumab for Stage IV Nonsquamous NSCLC: Is There Any Impact of Time Interval on Survival?" Clinical Medicine Insights: Oncology 2022: 1. https://doi.org/10.1177/11795549221106462.

MLA (9th ed.) Citation

Xiu, Weigang, et al. "Combination of Palliative Thoracic Radiotherapy With Bevacizumab for Stage IV Nonsquamous NSCLC: Is There Any Impact of Time Interval on Survival?" Clinical Medicine Insights: Oncology, 2022, p. 1, https://doi.org/10.1177/11795549221106462.